Clinical Trial Update: Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy [NA]

View source ↗

Summary

Clinical trial results show that acetyl-L-carnitine reduced depression and improved quality of life in patients with minimal hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Minimal Hepatic Encephalopathy

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: University of Catania | Conditions: Minimal Hepatic Encephalopathy | NA | Status: COMPLETED